Quadria Capital looks to exit from Indonesian drugmaker: sources

Carlye Group said to be sole bidder for 30% stake in Soho Global Health

Drugs

Soho Global Health produces generics, natural medicines, medical devices and consumer products. © Reuters

DEVIANA CHUO and AASTHA MAHESHWARI, DealStreetAsia

SINGAPORE/JAKARTA -- Quadria Capital is in late-stage talks with a global private equity firm to sell its stake in Indonesian pharmaceutical company Soho Global Health, sources familiar with the development told DealStreetAsia.

The health care-focused equity firm, which operates out of Singapore and New Delhi, has been approached by a slew of investors, including CVC Capital Partners, General Atlantic and the Carlyle Group.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.